The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression
Status:
Recruiting
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
To measure the effects of Microbial Ecosystem Therapeutics (MET)-2 on symptoms of depression
and anxiety using pre- and post-treatment scores for overall depression and anxiety